Segall Bryant & Hamill’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-6,183
Closed -$503K – 679
2023
Q2
$503K Sell
6,183
-7,202
-54% -$513K 0.01% 568
2023
Q1
$795K Sell
13,385
-7,475
-36% -$415K 0.01% 517
2022
Q4
$1.02M Sell
20,860
-305,919
-94% -$14.1M 0.01% 483
2022
Q3
$16.9M Buy
326,779
+115,019
+54% +$6.83M 0.2% 140
2022
Q2
$11.1M Buy
211,760
+43,665
+26% +$3.04M 0.13% 183
2022
Q1
$14.5M Buy
+168,095
New +$13.8M 0.14% 169

Other funds holding THC

Segall Bryant & Hamill's THC Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of Tenet Healthcare (THC) in Q3 2023, closing a stake of 6,183 shares — an estimated $503K sold.

Segall Bryant & Hamill first reported a position in THC in Q1 2022 and held it in 6 quarters. The position peaked at $16.9M in Q3 2022. 407 funds tracked by Wall St. Rank hold THC as of Q3 2023.

  • Segall Bryant & Hamill reported no remaining Tenet Healthcare position as of Q3 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 6,183 Tenet Healthcare shares in Q3 2023, an estimated $503K.
  • Segall Bryant & Hamill first reported a position in Tenet Healthcare in Q1 2022 and held it in 6 quarters.
  • Segall Bryant & Hamill's Tenet Healthcare position peaked at $16.9M in Q3 2022.
  • 407 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.